Several proteins, such as Mucin 16 (MUC16), have been evaluated as FGS targets in pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer [5,18,19,20,21,22,23,24]. This evidence concerns the gene MUC16 and pancreatic ductal adenocarcinoma.